XML 83 R52.htm IDEA: XBRL DOCUMENT
v3.22.4

Equity (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2022
Equity [Abstract] |
Equity - Outstanding number of shares [Text Block] | Philips Group Outstanding number of shares
| 2020 | 2021 | 2022
--- | --- | --- | ---
Balance as of January 1 | 890,973,790 | 905,128,293 | 870,182,445
Dividend distributed | 18,080,198 | 6,345,968 | 14,174,568
Purchase of treasury shares | (8,669,622) | (45,486,392) | (5,080,693)
Delivery of treasury shares | 4,695,170 | 4,194,577 | 2,204,207
Issuance of new shares | 48,757 |  |
Balance as of December 31 | 905,128,293 | 870,182,445 | 881,480,527
Equity - Transactions related to share-based compensation plans [Text Block] | Philips Group Transactions related to share-based compensation plans
| 2020 | 2021 | 2022
--- | --- | --- | ---
Shares acquired | 5,351,411 | 3,996,576 | 2,142,445
Average market price | EUR 33.81 | EUR 36.15 | EUR 31.76
Amount paid | EUR 181 million | EUR 144 million | EUR 68 million
Shares delivered | 4,695,170 | 4,194,577 | 2,204,207
Average price (FIFO) | EUR 34.35 | EUR 34.14 | EUR 35.16
Cost of delivered shares | EUR 161 million | EUR 143 million | EUR 77 million
Total shares in treasury at year-end | 5,924,708 | 5,726,708 | 5,664,946
Total cost | EUR 199 million | EUR 201 million | EUR 191 million
Equity - Transactions related to capital reduction [Text Block] | Philips Group Transactions related to capital reduction
| 2020 | 2021 | 2022
--- | --- | --- | ---
Shares acquired | 3,318,211 | 41,489,816 | 2,938,248
Average market price | EUR 39.21 | EUR 36.22 | EUR 36.61
Amount paid | EUR 130 million | EUR 1,503 million | EUR 108 million
Cancellation of treasury shares (shares) | 3,809,675 | 33,500,000 | 8,758,455
Cancellation of treasury shares (EUR) | EUR 152 million | EUR 1,216 million | EUR 299 million
Total shares in treasury at year-end |  | 7,989,816 | 2,169,609
Total cost |  | EUR 287 million | EUR 83 million
Equity - Composition of net debt and group equity [Text Block] | Philips Group Composition of net debt and group equity in millions of EUR unless otherwise stated
| 2020 | 2021 | 2022
--- | --- | --- | ---
Long-term debt | 5,705 | 6,473 | 7,270
Short-term debt | 1,229 | 506 | 931
Total debt | 6,934 | 6,980 | 8,201
Cash and cash equivalents | 3,226 | 2,303 | 1,172
Net debt | 3,708 | 4,676 | 7,028
Shareholders' equity | 11,870 | 14,438 | 13,249
Non-controlling interests | 31 | 36 | 34
Group equity | 11,901 | 14,475 | 13,283
Net debt and group equity ratio | 24:76 | 24:76 | 35:65
Equity - Adjusted income from continuing operations attributable to shareholders [Text Block] | Philips Group Adjusted income from continuing operations attributable to shareholders 1) in millions of EUR
| 2020 | 2021 | 2022
--- | --- | --- | ---
Net income | 1,195 | 3,323 | (1,605)
Discontinued operations, net of income taxes | (196) | (2,711) | (13)
Income from continuing operations | 999 | 612 | (1,618)
Income from continuing operations attributable to non-controlling interests | (8) | (4) | (3)
Income from continuing operations attributable to shareholders1) | 991 | 608 | (1,622)
Adjustments for: |  |  |
Amortization and impairment of acquired intangible assets | 377 | 322 | 363
Impairment of goodwill | 144 | 15 | 1,357
Restructuring costs and acquisition-related charges | 195 | 95 | 202
Other items: | 299 | 1,069 | 925
Respironics field-action provision |  | 719 | 250
Respironics field-action running remediation cost |  | 94 | 210
R&D project impairments |  |  | 134
Portfolio realignment charges |  |  | 109
Impairment of assets in S&RC |  |  | 39
Provision for public investigations tender irregularities |  |  | 60
Provisions for quality actions in Connected Care |  | 94 | 59
Loss on divestment of business |  | 76 |
Remaining items | 299 | 87 | 63
Net finance income/expenses | (125) | (84) | (4)
Tax impact of adjusted items and tax only adjusting items | (285) | (527) | (376)
Adjusted Income from continuing operations attributable to shareholders1) | 1,594 | 1,497 | 845
1)Shareholders in this table refers to shareholders of Koninklijke Philips N.V.

X
- References No definition available. + Details
Name: | ifrs-full_EquityAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | phg_EquityAdjustedIncomeFromContinuingOperationsAttributableToShareholdersTextBlock
Namespace Prefix: | phg_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | phg_EquityCompositionOfNetDebtAndGroupEquityTextBlock
Namespace Prefix: | phg_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | phg_EquityOutstandingNumberOfSharesTextBlock
Namespace Prefix: | phg_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | phg_EquityTransactionsRelatedToCapitalReductionTextBlock
Namespace Prefix: | phg_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | phg_EquityTransactionsRelatedToShareBasedCompensationPlansTextBlock
Namespace Prefix: | phg_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration